Brought to you by 
Axys/PPD genomics JV starts out with $60mm capitalization
13 Jul 1999
Executive Summary
Axys Pharmaceuticals (small-molecule drug discovery) has put its pharmacogenomics group together with the Intek Labs subsidiary operations of PPD Inc. (CRO) to form PPGx, which will sell pharmacogenomics services to Rx and biotech firms.
Deal Industry
- Contract Research, Toxicology Testing-CRO
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- Joint Venture
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Axys/PPD genomics JV starts out with $60mm capitalization
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice